Vahanian & Associates Financial Planning’s Altimmune ALT Stock Holding History

Vahanian & Associates Financial Planning’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$113K	Sell	10,000 -3,760	-27%	-$15.7K	0.44%	47
2023 Q3	$35.8K	Buy	+13,760	New	+$39.5K	0.11%	60
2023 Q2	–	Sell	-21,430	Closed	-$90.4K	–	55
2023 Q1	$90.4K	Buy	21,430 +4,300	+25%	+$51.1K	0.25%	73
2022 Q4	$282K	Sell	17,130 -250	-1%	-$2.81K	0.92%	40
2022 Q3	$222K	Buy	+17,380	New	+$257K	0.76%	44
2022 Q2	–	Sell	-31,426	Closed	-$191K	–	38
2022 Q1	$191K	Buy	+31,426	New	+$231K	0.44%	57

Other funds holding ALT

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Vahanian & Associates Financial Planning's ALT Position: Q4 2023 in Review

Vahanian & Associates Financial Planning reduced its Altimmune (ALT) stake by 27% in Q4 2023, selling an estimated $15.7K and leaving 10,000 shares worth $113K. The position accounts for 0.44% of the portfolio, ranked #47.

Vahanian & Associates Financial Planning first reported a position in ALT in Q1 2022 and has held it in 6 quarters since. The position peaked at $282K in Q4 2022. 143 funds tracked by Wall St. Rank hold ALT as of Q4 2023.

Vahanian & Associates Financial Planning held 10,000 shares of Altimmune worth $113K as of Q4 2023.
Vahanian & Associates Financial Planning sold 3,760 Altimmune shares in Q4 2023, an estimated $15.7K.
Altimmune made up 0.44% of Vahanian & Associates Financial Planning's portfolio in Q4 2023, its #47 holding.
Vahanian & Associates Financial Planning first reported a position in Altimmune in Q1 2022 and has held it in 6 quarters since.
Vahanian & Associates Financial Planning's Altimmune position peaked at $282K in Q4 2022.
143 funds tracked by Wall St. Rank held Altimmune as of Q4 2023.

Based on Vahanian & Associates Financial Planning's 13F filing for Q4 2023, filed 25 Jan 2024.